NNLX Stock Chart & Stats
<$0.01
>-$0.01(-20.00%)
At close: 4:00 PM EDT
<$0.01
>-$0.01(-20.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume12.23K
Average Volume (3M)N/A
Market Cap
$9.57K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-132.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding119,611,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NNLX FAQ
What was Nanologix Inc’s price range in the past 12 months?
Nanologix Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Nanologix Inc’s market cap?
Nanologix Inc’s market cap is $9.57K.
When is Nanologix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nanologix Inc’s earnings last quarter?
Currently, no data Available
Is Nanologix Inc overvalued?
According to Wall Street analysts Nanologix Inc’s price is currently Overvalued.
Does Nanologix Inc pay dividends?
Nanologix Inc does not currently pay dividends.
What is Nanologix Inc’s EPS estimate?
Nanologix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanologix Inc have?
Nanologix Inc has 119,611,000 shares outstanding.
What happened to Nanologix Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nanologix Inc?
Currently, no hedge funds are holding shares in NNLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanologix Inc
NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting with organic, inorganic molecules, and proteins. Another significant product is the FlatPack Petri Plate, essential for the isolation and cultivation of diverse microorganisms, including both fastidious and non-fastidious types, as well as those requiring or not requiring oxygen for growth (aerobic and anaerobic respectively). The company's solutions are applied across a broad spectrum of sectors, including medical diagnostics, national defense, homeland security initiatives, pharmaceutical research and manufacturing, industrial processes, veterinary science, and environmental monitoring. NanoLogix serves an established clientele comprising prominent medical and scientific organizations. This includes laboratories, healthcare institutions, academic universities, various businesses, and specialized research establishments. Headquartered in Hubbard, Ohio, NanoLogix, Inc. operates from this location.
Technical Analysis
―
Scinai Immunotherapeutics
―
Aditxt
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors